We present the synthesis, photophysical properties, and biological application of nontoxic 3-azo-conjugated BODIPY dyes as masked fluorescent biosensors of hypoxia-like conditions. The synthetic methodology is based on an operationally simple N═N bond-forming protocol, followed by a Suzuki coupling, that allows for a direct access to simple and underexplored 3-azo-substituted BODIPY. These dyes can turn on their emission properties under both chemical and biological reductive conditions, including bacterial and human azoreductases, which trigger the azo bond cleavage, leading to fluorescent 3-amino-BODIPY. We have also developed a practical enzymatic protocol, using an immobilized bacterial azoreductase that allows for the evaluation of these azo-based probes and can be used as a model for the less accessible and expensive human reductase NQO1. Quantum mechanical calculations uncover the restructuration of the topography of the S1 potential energy surface following the reduction of the azo moiety and rationalize the fluorescent quenching event through the mapping of an unprecedented pathway. Fluorescent microscopy experiments show that these azos can be used to visualize hypoxia-like conditions within living cells.
8 January 2025 in Colloids and Surfaces B: Biointerfaces
Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer defined by the lack of three key receptors: estrogen, progesterone, and HER2. This lack of receptors makes TNBC difficult to treat with hormone therapy or drugs, and so it is characterised by a poor prognosis compared to other kinds of breast cancer. This study explores photoactive Poly(lactic-co-glycolic acid) (PLGA) nanoparticles as a potential therapeutic strategy for TNBC. The nanoparticles are functionalised with hyaluronic acid (HA) for targeted delivery to CD-44 receptors overexpressed in TNBC cells, especially under hypoxic conditions. Additionally, we co-loaded the nanoparticles with Doxorubicin (Dox) and Indocyanine Green (ICG) to enable combinatorial chemo-photothermal therapy. After carefully optimising the formulation, we propose an effortless and reproducible preparation of the nanodrugs. We demonstrate that HA-conjugated nanoparticles effectively target TNBC cells and inhibit their proliferation while the treatment efficiency is enhanced during near-infrared light irradiation. We also prove that our treatment is effective in a 3D cell culture model, highlighting the importance of tumour architecture and the metabolic stage of the cells in the tumour microenvironment. This approach is promising for a tumour-targeted theragnostic for TNBC with improved efficacy in hypoxic microenvironments.
27 November 2024 in Journal of Materials Chemistry C
In this work, a hypoxia-sensitive nanoprobe is developed by coating the surface of upconverting core/shell nanoparticles (NaGdF4: 2%Yb3+, 3%Nd3+, 0.2%Tm3+/NaYF4) with a non-fluorescent azo-dye based on a boron-dipyrromethene functionalized azo compound. Azo-dyes are able to quench fluorescence emissions due to their NN azo bond, which results in the absorption of most visible emissions of the nanoparticles. However, in a biological environment suffering hypoxia, the azo bond is reduced, which allows the recovery of the nanoparticles’ upconversion emissions. Thereby a near-infrared excitable sensor with an azo-dye is created and for the first time not only enables excitation via NIR at biocompatible 808 nm but also continuous imaging and tracking of the probe in the infrared due to NIR-emissions enabled by the dopant combination since quenching only occurs in the visible. These multifunctional (imaging and sensing) nanoparticles are characterized, their behaviour in reductive and hypoxic environments is determined and the detection of reducing conditions in a hypoxic environment is demonstrated in cells.
Photodynamic therapy (PDT) is a minimally invasive technique—used for the local eradication of neoplastic cells—that exploits the interaction of light, oxygen, and a photo-responsive drug called photosensitizer (PS) for the local generation of lethal ROS. Push-pull chromophores, that bear electron donor (D) and acceptor (A) groups linked through a π-electron bridge, are characterized by a non-homogeneous charge distribution in their excited state, with charge transfer from one extremity of the chain to the other one (Internal Charge Transfer—ICT). This phenomenon has a direct impact on the photophysical features of the push-pull compounds, as the bathochromic shift of the emission maxima and intersystem crossing (ISC) of the excited state are directly connected with the production of reactive oxygen species (ROS). In continuing our research regarding the synthesis and use of oligophenylene ethynylenes (OPEs) in PDT, two new push-pull glycosyl OPE-NOF and OPE-ONF—featuring electron-donor N,N-dimethylamino (N) and dimetoxyaryl (O) and acceptor tetrafluoroaryl (F) moieties on the OPE chain—have been efficiently prepared. The interchanged position of the D groups onto the conjugated skeleton was aimed to tune and optimize the push-pull effect, while the introduction of glucoside terminations was directed to give biocompatibility and bioaffinity to the chromophores. OPE-NOF, OPE-ONF, and the synthetic intermediates were fully characterized, and their photophysical properties were investigated by using UV-Vis absorption and emission spectroscopy. OPE-NOF showed a strong charge-transfer character and high PDT effect on HeLa cancer cells when irradiated with non-harmful blue light, causing massive cancer cell death.